Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2008, Article ID 394802, 6 pages
http://dx.doi.org/10.1155/2008/394802
Research Article

Jaceosidin Induces Apoptosis in Human Ovary Cancer Cells through Mitochondrial Pathway

1The Second Affiliated Hospital, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
2State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China

Received 14 January 2008; Accepted 6 July 2008

Academic Editor: Wolfgang Schulz

Copyright © 2008 Wen Lv et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. B. Weinstein, “Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis,” Carcinogenesis, vol. 21, no. 5, pp. 857–864, 2000. View at Publisher · View at Google Scholar
  2. T. Jacks and R. A. Weinberg, “Taking the study of cancer cell survival to a new dimension,” Cell, vol. 111, no. 7, pp. 923–925, 2002. View at Publisher · View at Google Scholar
  3. C. Chen and A.-N. T. Kong, “Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects,” Trends in Pharmacological Sciences, vol. 26, no. 6, pp. 318–326, 2005. View at Publisher · View at Google Scholar
  4. J. M. Cline and C. L. Hughes Jr., “Phytochemicals for the prevention of breast and endometrial cancer,” Cancer Treatment and Research, vol. 94, pp. 107–134, 1998. View at Google Scholar
  5. M.-S. Kim, H.-J. Kang, and A. Moon, “Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells,” Archives of Pharmacal Research, vol. 24, no. 4, pp. 349–354, 2001. View at Google Scholar
  6. U. Wenzel, S. Kuntz, M. D. Brendel, and H. Daniel, “Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells,” Cancer Research, vol. 60, no. 14, pp. 3823–3831, 2000. View at Google Scholar
  7. T. Nakasugi, M. Nakashima, and K. Komai, “Antimutagens in gaiyou (Artemisia argyi Levl. et Vant.),” Journal of Agricultural and Food Chemistry, vol. 48, no. 8, pp. 3256–3266, 2000. View at Publisher · View at Google Scholar
  8. G. R. Schinella, R.-M. Giner, M. Del Carmen Recio, P. M. De Buschiazzo, J.-L. Ríos, and S. Máñez, “Anti-inflammatory effects of South American Tanacetum vulgare,” Journal of Pharmacy and Pharmacology, vol. 50, no. 9, pp. 1069–1074, 1998. View at Google Scholar
  9. H.-J. Seo, K.-K. Park, S. S. Han et al., “Inhibitory effects of the standardized extract (DA-9601) of Artemisia asiatica Nakai on phorbol ester-induced ornithine decarboxylase activity, papilloma formation, cyclooxygenase-2 expression, inducible nitric oxide synthase expression and nuclear transcription factor ?B activation in mouse skin,” International Journal of Cancer, vol. 100, no. 4, pp. 456–462, 2002. View at Publisher · View at Google Scholar
  10. Y. Sun, Y. H. Li, X. X. Wu et al., “Ethanol extract from Artemisia vestita, a traditional Tibetan medicine, exerts anti-sepsis action through down-regulating the MAPK and NF-?B pathways,” International Journal of Molecular Medicine, vol. 17, no. 5, pp. 957–962, 2006. View at Google Scholar
  11. M. A. Jeong, K. W. Lee, D.-Y. Yoon, and H. J. Lee, “Jaceosidin, a pharmacologically active flavone derived from Artemisia argyi, inhibits phorbol-ester-induced upregulation of COX-2 and MMP-9 by blocking phosphorylation of ERK-1 and -2 in cultured human mammary epithelial cells,” Annals of the New York Academy of Sciences, vol. 1095, no. 1, pp. 458–466, 2007. View at Publisher · View at Google Scholar
  12. H.-G. Lee, K.-A. Yu, W.-K. Oh et al., “Inhibitory effect of jaceosidin isolated from Artemisia argyi on the function of E6 and E7 oncoproteins of HPV 16,” Journal of Ethnopharmacology, vol. 98, no. 3, pp. 339–343, 2005. View at Publisher · View at Google Scholar
  13. M.-J. Kim, D.-H. Kim, K. W. Lee, D.-Y. Yoon, and Y.-J. Surh, “Jaceosidin induces apoptosis in ras-transformed human breast epithelial cells through generation of reactive oxygen species,” Annals of the New York Academy of Sciences, vol. 1095, no. 1, pp. 483–495, 2007. View at Publisher · View at Google Scholar
  14. R. N. Buick, R. Pullano, and J. M. Trent, “Comparative properties of five human ovarian adenocarcinoma cell lines,” Cancer Research, vol. 45, no. 8, pp. 3668–3676, 1985. View at Google Scholar
  15. H. Morimoto, J. T. Safrit, and B. Bonavida, “Synergistic effect of tumor necrosis factor-α- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines,” The Journal of Immunology, vol. 147, no. 8, pp. 2609–2616, 1991. View at Google Scholar
  16. M. E. Kaighn, K. S. Narayan, Y. Ohnuki, J. F. Lechner, and L. W. Jones, “Establishment and characterization of a human prostatic carcinoma cell line (PC-3),” Investigative Urology, vol. 17, no. 1, pp. 16–23, 1979. View at Google Scholar
  17. W. F. Scherer, J. T. Syverton, and G. O. Gey, “Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix,” The Journal of Experimental Medicine, vol. 97, pp. 695–710, 1953. View at Publisher · View at Google Scholar
  18. J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics,” British Journal of Cancer, vol. 26, no. 4, pp. 239–257, 1972. View at Google Scholar
  19. Y. A. Hannun, “Apoptosis and the dilemma of cancer chemotherapy,” Blood, vol. 89, no. 6, pp. 1845–1853, 1997. View at Google Scholar
  20. S. Sen and M. D'Incalci, “Apoptosis biochemical events and relevance to cancer chemotherapy,” FEBS Letters, vol. 307, no. 1, pp. 122–127, 1992. View at Publisher · View at Google Scholar
  21. D. R. Green and J. C. Reed, “Mitochondria and apoptosis,” Science, vol. 281, no. 5381, pp. 1309–1312, 1998. View at Publisher · View at Google Scholar
  22. M. Castedo, A. Macho, N. Zamzami et al., “Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo,” European Journal of Immunology, vol. 25, no. 12, pp. 3277–3284, 1995. View at Publisher · View at Google Scholar
  23. A. B. Granado-Serrano, M. A. Martín, L. Bravo, L. Goya, and S. Ramos, “Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2),” The Journal of Nutrition, vol. 136, no. 11, pp. 2715–2721, 2006. View at Google Scholar
  24. P. Li, D. Nijhawan, I. Budihardjo et al., “Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade,” Cell, vol. 91, no. 4, pp. 479–489, 1997. View at Publisher · View at Google Scholar
  25. S. M. Srinivasula, M. Ahmad, T. Fernandes-Alnemri, and E. S. Alnemri, “Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization,” Molecular Cell, vol. 1, no. 7, pp. 949–957, 1998. View at Publisher · View at Google Scholar
  26. W. C. Earnshaw, L. M. Martins, and S. H. Kaufmann, “Mammalian caspases: structure, activation, substrates, and functions during apoptosis,” Annual Review of Biochemistry, vol. 68, pp. 383–424, 1999. View at Publisher · View at Google Scholar
  27. D. W. Nicholson, “Caspase structure, proteolytic substrates, and function during apoptotic cell death,” Cell Death & Differentiation, vol. 6, no. 11, pp. 1028–1042, 1999. View at Publisher · View at Google Scholar
  28. T. Walle, N. Ta, T. Kawamori, X. Wen, P. A. Tsuji, and U. K. Walle, “Cancer chemopreventive properties of orally bioavailable flavonoids—methylated versus unmethylated flavones,” Biochemical Pharmacology, vol. 73, no. 9, pp. 1288–1296, 2007. View at Publisher · View at Google Scholar